Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement
, , , , and
Math. Model. Nat. Phenom., 2 3 (2007) 47-68
Published online: 15 June 2008
DOI: 10.1051/mmnp:2007003